Antibiotic resistance: current challenges and ways of their solution

O Viltsaniuk; V Syvak; Y Vovk; L Bondar; K Taraniuk

doi:10.31636/prmd.v7i1.6

Автор(и)

O Viltsaniuk National Pirogov Memorial Medical University, Vinnytsia.
V Syvak Military Medical Clinical Center of the Central Region, Ukraine
Y Vovk Military Medical Clinical Center of the Central Region, Ukraine
L Bondar Military Medical Clinical Center of the Central Region, Ukraine
K Taraniuk Military Medical Clinical Center of the Central Region, Ukraine.

DOI:

https://doi.org/10.31636/prmd.v7i1.6

Ключові слова:

антибіотикорезистентність, мультирезистентність, еволюція антибіотикорезистентності, шляхи подолання

Анотація

Залучення антибіотиків у різні сфери життя людей та у різні галузі життєдіяльності суспільства призвело до виникнення антибіотикорезистентності. Пандемії та розв’язання військових конфліктів у різних країнах світу, зокрема і в Україні, також накладають свій відбиток на еволюцію збудників та їхню антибіотикорезистентність, що пов’язано з обмеженням санітарно-гігієнічних потреб людей, відсутністю адекватної медичної допомоги, великої міграції людей та безконтрольного використання антибіотиків. У даній статті розглянуті основні дії мікроорганізмів, спрямовані на захист від антибіотиків залежно від видової приналежності. Проведено аналіз ряду публікацій для вивчення та висвітлення основних необхідних кроків, запропонованих різними авторами, щодо подолання даної проблеми як в галузі охорони здоров’я, так і в суспільстві

Завантажити

Дані для завантаження поки недоступні.

Посилання

1. Hussain HI, Aqib AI, Seleem MN, Shabbir MA, Hao H, Iqbal Z, et al. Genetic basis of molecular mechanisms in β-lactam resistant gram-negative bacteria. Microbial Pathogenesis [Internet]. 2021 Sep;158:105040. Available from: https://doi.org/10.1016/j.micpath.2021.105040

2. Bryce A, Hay AD, Lane IF, Thornton HV, Wootton M, Costelloe C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused byEscherichia coliand association with routine use of antibiotics in primary care: systematic review and meta-analysis. BMJ [Internet]. 2016 Mar 15;352:i939. Available from: https://doi.org/10.1136/bmj.i939

3. Pilmis B, Le Monnier A, Zahar JR. Gut Microbiota, Antibiotic Therapy and Antimicrobial Resistance: A Narrative Review. Microorganisms [Internet]. 2020 Feb 17;8(2):269. Available from: https://doi.org/10.3390/microorganisms8020269

4. Alshubaily AM, Alosaimi AS, Alhothli BI, Althawadi SI, Alghamdi SM. Risk of invasive MDRO infection in MDRO-colonized patients. Infection Control & Hospital Epidemiology [Internet]. 2024 Oct 14;1–5. Available from: https://doi.org/10.1017/ice.2024.156

5. Romero LC, de Souza da Cunha M de LR. Insights into the epidemiology of community-associated methicillin-resistant Staphylococcus aureus in special populations and at the community-healthcare interface. The Brazilian Journal of Infectious Diseases [Internet]. 2021 Nov;25(6):101636. Available from: https://doi.org/10.1016/j.bjid.2021.101636

6. Jaradat ZW, Ababneh QO, Sha’aban ST, Alkofahi AA, Assaleh D, Al Shara A. Methicillin Resistant Staphylococcus aureus and public fomites: a review. Pathogens and Global Health [Internet]. 2020 Oct 28;114(8):426–50. Available from: https://doi.org/10.1080/20477724.2020.1824112

7. Eichel VM, Last K, Brühwasser C, von Baum H, Dettenkofer M, Götting T, et al. Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis. Journal of Hospital Infection [Internet]. 2023 Nov;141:119–28. Available from: https://doi.org/10.1016/j.jhin.2023.09.008

8. Silva RTP da, Rocha IV, Dantas TF, Silva J dos S, Costa Júnior SD da, Luz AC de O, et al. Emergence and spread of resistant and biofilm-forming Acinetobacter baumannii in critically ill COVID-19 patients. Microbial Pathogenesis [Internet]. 2024 Dec;197:107078. Available from: https://doi.org/10.1016/j.micpath.2024.107078

9. Howard A, O’Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii. Virulence [Internet]. 2012 May;3(3):243–50. Available from: https://doi.org/10.4161/viru.19700

10. Bergogne-Bérézin E. Acinetobacter spp., Saprophytic Organisms of Increasing Pathogenic Importance. Zentralblatt für Bakteriologie [Internet]. 1994 Nov;281(4):389–405. Available from: https://doi.org/10.1016/s0934-8840(11)80326-9

11. Bergogne-Bérézin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clinical Microbiology Reviews [Internet]. 1996 Apr;9(2):148–65. Available from: https://doi.org/10.1128/cmr.9.2.148

12. Kämpfer P. Acinetobacter. In: Batt CA, Tortorello ML, editors. Encyclopedia of Food Microbiology. 2nd ed. Oxford UK: Academic Press; 2014. P. 11–17.

13. Jung SY, Lee SH, Lee SY, Yang S, Noh H, Chung EK, et al. Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis. Critical Care [Internet]. 2017 Dec;21(1):319. Available from: https://doi.org/10.1186/s13054-017-1916-6

14. Ferlicolak L, Altintas ND, Yoruk F. A retrospective analysis of carbapenem-resistant Acinetobacter baumannii infections in critically ill patients: Experience at a tertiary-care teaching hospital ICU. Journal of Intensive Medicine [Internet]. 2024 Apr;4(2):181–6. Available from: https://doi.org/10.1016/j.jointm.2023.11.004

15. Deshwal PR, Fathima R, Aggarwal M, Reddy NS, Tiwari P. A systematic review and meta-analysis for risk factor profiles in patients with resistant Acinetobacter baumannii infection relative to control patients. International Journal of Risk & Safety in Medicine [Internet]. 2023 Dec 7;34(4):337–55. Available from: https://doi.org/10.3233/jrs-220037

16. Matos ECO de, Andriolo RB, Rodrigues YC, Lima PDL de, Carneiro IC do RS, Lima KVB. Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis. Revista da Sociedade Brasileira de Medicina Tropical [Internet]. 2018 Aug;51(4):415–20. Available from: https://doi.org/10.1590/0037-8682-0506-2017

17. Zavascki AP, Barth AL, Gonçalves AL, Moro AL, Fernandes JF, Martins AF, et al. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother [Internet]. 2006 May 30;58(2):387–92. Available from: https://doi.org/10.1093/jac/dkl239

18. Furtado GH, Bergamasco MD, Menezes FG, Marques D, Silva A, Perdiz LB, et al. Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: risk factors and mortality. Journal of Critical Care [Internet]. 2009 Dec;24(4):625.e9-625.e9-14. Available from: https://doi.org/10.1016/j.jcrc.2009.03.006

19. Matos EC, Matos HJ, Conceição ML, Rodrigues YC, Carneiro IC, Lima KV. Clinical and microbiological features of infections caused by Pseudomonas aeruginosa in patients hospitalized in intensive care units. Revista da Sociedade Brasileira de Medicina Tropical [Internet]. 2016 Jun;49(3):305–11. Available from: https://doi.org/10.1590/0037-8682-0446-2015

20. Chen X, Zhou M, Yan Q, Jian Z, Liu W, Li H. Risk factors for carbapenem-resistant Enterobacterales infection among hospitalized patients with previous colonization. Journal of clinical laboratory analysis [Internet]. 2022;36(11):e24715. Available from: https://doi.org/10.1002/jcla.24715

21. Lin XC, Li CL, Zhang SY, Yang XF, Jiang M. The Global and Regional Prevalence of Hospital-Acquired Carbapenem-Resistant Klebsiella pneumoniae Infection: A Systematic Review and Meta-analysis. Open forum infectious diseases [Internet]. 2023 Dec 19;11(2):ofad649. Available from: https://doi.org/10.1093/ofid/ofad649

22. Sholeh M, Krutova M, Forouzesh M, Mironov S, Sadeghifard N, Molaeipour L, et al. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis. Antimicrobial Resistance & Infection Control [Internet]. 2020 Sep 25;9(1):158. Available from: https://doi.org/10.1186/s13756-020-00815-5

23. Spigaglia P, Mastrantonio P, Barbanti F. Antibiotic Resistances of Clostridioides difficile. Advances in experimental medicine and biology [Internet]. 2024;1435:169-198. Available from: https://doi.org/ 10.1007/978-3-031-42108-2_9

24. Salmanov A, Shchehlov D, Svyrydiuk O, Bortnik I, Mamonova M, Korniyenko S, et al. Epidemiology of healthcare-associated infections and mechanisms of antimicrobial resistance of responsible pathogens in Ukraine: a multicentre study. Journal of Hospital Infection [Internet]. 2023 Jan;131:129–38. Available from: https://doi.org/10.1016/j.jhin.2022.10.007

25. Yan ZQ, Shen DX, Cao JR, Chen R, Wei X, Liu LP, et al. Susceptibility patterns and molecular epidemiology of multidrug-resistant Acinetobacter baumannii strains from three military hospitals in China. International Journal of Antimicrobial Agents [Internet]. 2010 Mar;35(3):269–73. Available from: https://doi.org/10.1016/j.ijantimicag.2009.10.016

26. Berger FK, Schmartz GP, Fritz T, Veith N, Alhussein F, Roth S, et al. Occurrence, resistance patterns, and management of carbapenemase-producing bacteria in war-wounded refugees from Ukraine. International Journal of Infectious Diseases [Internet]. 2023 Jul;132:89–92. Available from: https://doi.org/10.1016/j.ijid.2023.04.394

27. Kovalchuk V, Kondratiuk V, McGann P, Jones BT, Fomina N, Nazarchuk O, et al. Temporal evolution of bacterial species and their antimicrobial resistance characteristics in wound infections of war-related injuries in Ukraine from 2014 to 2023. Journal of Hospital Infection [Internet]. 2024 Oct;152:99–104. Available from: https://doi.org/10.1016/j.jhin.2024.06.011

28. Granata G, Petersen E, Capone A, Donati D, Andriolo B, Gross M, et al. The impact of armed conflict on the development and global spread of antibiotic resistance: a systematic review. Clinical Microbiology and Infection [Internet]. 2024 Jul;30(7):858–65. Available from: https://doi.org/10.1016/j.cmi.2024.03.029

29. Brown, L. et al. Antibiotic Resistance in Conflict Zones: A Systematic Review. Lancet Infectious Diseases. 2021.

30. Smith, J., et al. The impact of diagnostic testing on antibiotic resistance: A meta-analysis. Journal of Antimicrobial Chemotherapy. 2022;77(4):1127–1135.

31. Pallett SJC, Boyd SE, O’Shea MK, Martin J, Jenkins DR, Hutley EJ. The contribution of human conflict to the development of antimicrobial resistance. Communications Medicine [Internet]. 2023 Oct 25;3(1):153. Available from: https://doi.org/10.1038/s43856-023-00386-7

32. Ljungquist O, Nazarchuk O, Kahlmeter G, Andrews V, Koithan T, Wasserstrom L, et al. Highly multidrug-resistant Gram-negative bacterial infections in war victims in Ukraine, 2022. The Lancet Infectious Diseases [Internet]. 2023 Jul;23(7):784–6. Available from: https://doi.org/10.1016/s1473-3099(23)00291-8

33. Pallett SJC, Trompeter A, Basarab M, Moore LSP, Boyd SE. Multidrug-resistant infections in war victims in Ukraine. The Lancet Infectious Diseases [Internet]. 2023 Aug;23(8):e270–1. Available from: https://doi.org/10.1016/s1473-3099(23)00391-2

34. Granata G, Petersen E, Capone A, Donati D, Andriolo B, Gross M, et al. The impact of armed conflict on the development and global spread of antibiotic resistance: a systematic review. Clinical Microbiology and Infection [Internet]. 2024 Jul;30(7):858–65. Available from: https://doi.org/10.1016/j.cmi.2024.03.029

35. Pallett S, Charani E, Hawkins L, Mazzella A, Anton-Vazquez V, Banerjee R, et al. National action plans for antimicrobial resistance and variations in surveillance data platforms. Bulletin of the World Health Organization [Internet]. 2023 Aug 1;101(08):501-512F. Available from: https://doi.org/10.2471/blt.22.289403

36. Jones A, et al. Targeted versus broad-spectrum antibiotics: A systematic review and meta-analysis. Clinical Infectious Diseases. 2021;72(3):450–458.

37. Brown C, et al. Adherence to antibiotic therapy and its impact on clinical outcomes: A systematic review. Infection Control & Hospital Epidemiology. 2020;41(8):922–929.

38. Miller L, et al. Educating patients about antibiotic resistance: Impact on prescribing behavior. American Journal of Infection Control. 2019;47(10):1205–1210.

39. Clark T, et al. Non-antibiotic therapies in viral infections: A meta-analysis of their impact on antibiotic use. The Journal of Infectious Diseases. 2021;224(6):963–970.

40. Davis R, et al. Infection control protocols and their effectiveness in reducing hospital-acquired infections: A meta-analysis. Infection Control & Hospital Epidemiology. 2020;41(1):78–86.

41. Thompson A, et al. Vaccination impact on antibiotic prescribing in respiratory infections: A systematic review. Clinical Microbiology and Infection. 2022;28(2):175–182.

42. The effectiveness of antimicrobial stewardship programs: A meta-analysis. BMJ Quality & Safety. 30(5):362–371.

43. Novel antibiotics for multidrug-resistant infections: A systematic review and meta-analysis. The Lancet Infectious Diseases. 23(1):23–35.

44. Global trends in antibiotic resistance: A meta-analysis. Nature Reviews Microbiology. 18(5):333–343.